Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Dose Escalation Trial of the Combination of Osimertinib and Quaratusugene Ozeplasmid Gene Therapy in Patients with Advanced NSCLC.
Journal: Clinical lung cancer
Published: June 10, 2025
Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 22, 2023
Showing 1-2 of 2
Last Updated: 09/26/2026